跳至主要内容
临床试验/IRCT201505301165N4
IRCT201505301165N4已完成3 期

Evaluation of anti-oxidant and anti-inflammatory effects of Curcumin in type 2 diabetes patients

Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • diagnosis of type 2 diabetes (FBS =126 mg/dl, HbA1C =6.5%); type 2 diabetes patients under standard anti-diabetics agents; adult patients (18 to 65 year old).
  • Exclusion criteria: pregnancy or breast feeding; lack of compliance with the study medication; impossibility to give informed consent; participation on an other concomitant clinical trial; presence of malignancies; chronic liver disease (ALT = 3 folds of upper limit of normal value range; renal failure (serum creatinine =2.0 mg/dL or on dialysis); subjects receiving hormonal agents; subjects receiving other herbal medicines; subjects with secondary causes of hyperglycemia (receiving steroids or with pancreatic cancer)
  • subjects with acute infections or chronic inflammatory diseases (rheumatoid arthritis); hypersensitivity to the study medication; endocrine disease (hypothyroidism or hyperthyroidism); obsessive compulsive disorder.

排除标准

  • 未提供

研究者

发起方
Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences

相似试验